Inhibitor Therapeutics, Inc.
INTI
$0.0514
-$0.0086-14.33%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -36.57% | -33.12% | -29.72% | -28.76% | -26.03% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -19.60% | 4.28% | 28.62% | 115.33% | 356.90% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -36.37% | -32.85% | -29.38% | -28.07% | -25.27% |
|
|||||
Total Current Assets | -36.37% | -32.85% | -29.38% | -28.07% | -25.27% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -36.37% | -32.85% | -29.38% | -28.07% | -25.27% |
|
|||||
Total Accounts Payable | -52.82% | -98.17% | 59.32% | 2,138.00% | -76.79% |
Total Accrued Expenses | 9.87% | -32.23% | -47.98% | -40.19% | 415.01% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 6.67% | -71.48% | -19.13% | 98.85% | -2.00% |
|
|||||
Total Current Liabilities | 6.67% | -71.48% | -19.13% | 98.85% | -2.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Liabilities | 1.21% | -3.54% | -0.28% | 2.52% | -0.37% |
|
|||||
Common Stock & APIC | 0.07% | 0.07% | 0.08% | 0.10% | 0.03% |
Retained Earnings | -6.85% | -6.48% | -6.43% | -6.85% | -6.61% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -62.43% | -47.19% | -41.84% | -40.20% | -36.31% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -62.43% | -47.19% | -41.84% | -40.20% | -36.31% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -62.43% | -47.19% | -41.84% | -40.20% | -36.31% |
|